SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-16-125081
Filing Date
2016-06-02
Accepted
2016-06-02 14:30:37
Documents
1
Group Members
BARBARA N. LUBASHBRADLEY J. BOLZONBRIAN G. ATWOODCHARLES M. WARDENDONALD B. MILDERREBECCA B. ROBERTSONROBIN L. PRAEGERROSS A. JAFFESAMUEL D. COLELLAVERSANT SIDE FUND III, L.P.VERSANT VENTURES III, LLCWILLIAM J. LINK

Document Format Files

Seq Description Document Type Size
1 SC 13D a16-12723_1sc13d.htm SC 13D 366172
  Complete submission text file 0001104659-16-125081.txt   368210
Mailing Address 410 WEST HARRISON STREET SUITE 300 SEATTLE WA 98119
Business Address 410 WEST HARRISON STREET SUITE 300 SEATTLE WA 98119 206-805-6300
PHASERX, INC. (Subject) CIK: 0001429386 (see all company filings)

IRS No.: 204690620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89513 | Film No.: 161692172
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-2211
Versant Venture Capital III, L.P. (Filed by) CIK: 0001456586 (see all company filings)

IRS No.: 203659276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D